Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments - 24/02/22

Doi : 10.1016/j.psc.2021.11.006

Osnat C. Melamed, MD, MSc ^a,^b, Wayne K. deRuiter, PhD ^a, Leslie Buckley, MD, MPH ^c,^d, Peter Selby, MBBS, MHSc ^a,^b,^d,^e,^⁎
^a Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, Ontario M6J1H4, Canada
^b Department of Family and Community Medicine, University of Toronto, 500 University Avenue, Toronto, Ontario M5G1V7, Canada
^c Addictions Division, Centre for Addiction and Mental Health, 1001 Queen Street West, Toronto, Ontario M6J1H4, Canada
^d Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario M5T1R8, Canada
^e Dalla Lana School of Public Health, University of Toronto, 155 College Street Room 500, Toronto, Ontario M5T3M7, Canada

^∗Corresponding author. Nicotine Dependence Service, Centre for Addiction and Mental Health, 1025 Queen Street West, Toronto, Ontario M6J1H4, Canada.Nicotine Dependence ServiceCentre for Addiction and Mental Health1025 Queen Street WestTorontoOntarioM6J1H4Canada

connectez-vous ou créez un compte

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Coronavirus disease 2019 (COVID-19)-related stressors and restrictions, in the absence of social and institutional support, have led many individuals to either increase their substance consumption or relapse. Consequently, treatment programs for substance use disorders (SUDs) made a transition from in-person to remote care delivery. This review discusses the following evidence regarding changes prompted by the COVID pandemic to the clinical care of individuals with SUDs: (1) reduction in availability of care, (2) increase in demand for care, (3) transition to telemedicine use, (4) telemedicine for treatment of opioid use disorders, and (5) considerations for use of telemedicine in treating SUDs.

Le texte complet de cet article est disponible en PDF.

Keywords : COVID-19, Pandemic, Substance use disorder treatment, Opioid use disorder, Digital technology, Telemedicine